BioCentury
ARTICLE | Financial News

Amicus raises $300M in bumped-up follow-on

February 23, 2018 3:25 PM UTC

Amicus Therapeutics Inc. (NASDAQ:FOLD) raised $300 million on Feb. 15 through the sale of 19.4 million shares at $15.50 in an upsized follow-on underwritten by J.P. Morgan, Goldman Sachs, Cowen, Leerink and BofA Merrill Lynch. The price is a 1% discount to Amicus' close at $15.68 on Feb. 14, when it proposed after market hours to raise $250 million...

BCIQ Company Profiles

Amicus Therapeutics Inc.